Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project).

Bravi CA, Larcher A, Capitanio U, Mari A, Antonelli A, Artibani W, Barale M, Bertini R, Bove P, Brunocilla E, Da Pozzo L, Di Maida F, Fiori C, Gontero P, Li Marzi V, Longo N, Mirone V, Montanari E, Porpiglia F, Schiavina R, Schips L, Simeone C, Siracusano S, Terrone C, Trombetta C, Volpe A, Montorsi F, Ficarra V, Carini M, Minervini A.

Eur Urol Focus. 2019 Nov 11. pii: S2405-4569(19)30335-9. doi: 10.1016/j.euf.2019.10.013. [Epub ahead of print]

PMID:
31727523
2.

Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.

De Cobelli F, Papa M, Panzeri M, Colombo M, Steidler S, Ambrosi A, Cao R, Gusmini S, Marra P, Capitanio U, Bertini R, Venturini M, Losa A, Gaboardi F, Montorsi F, Cardone G.

Cardiovasc Intervent Radiol. 2019 Aug 26. doi: 10.1007/s00270-019-02313-7. [Epub ahead of print]

PMID:
31451888
3.

Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer.

Capitanio U, Larcher A, Cianflone F, Trevisani F, Nini A, Mottrie A, Mari A, Campi R, Tellini R, Briganti A, Veccia A, Van Poppel H, Carini M, Simeone C, Salonia A, Minervini A, Antonelli A, Montorsi F, Bertini R.

Eur Urol Oncol. 2019 Mar 25. pii: S2588-9311(19)30030-6. doi: 10.1016/j.euo.2019.02.006. [Epub ahead of print]

PMID:
31411993
4.

On-clamp versus off-clamp partial nephrectomy: Propensity score-matched comparison of long-term functional outcomes.

Simone G, Capitanio U, Tuderti G, Presicce F, Leonardo C, Ferriero M, Misuraca L, Costantini M, Larcher A, Minisola F, Guaglianone S, Anceschi U, Muttin F, Nini A, Trevisani F, Montorsi F, Bertini R, Gallucci M.

Int J Urol. 2019 Oct;26(10):985-991. doi: 10.1111/iju.14079. Epub 2019 Jul 24.

PMID:
31342589
5.

Two new species of ascaridoid nematodes in Brazilian Crocodylomorpha from the Upper Cretaceous.

Cardia DFF, Bertini RJ, Camossi LG, Letizio LA.

Parasitol Int. 2019 Oct;72:101947. doi: 10.1016/j.parint.2019.101947. Epub 2019 Jun 21.

PMID:
31233826
6.

First record of Acanthocephala parasites eggs in coprolites preliminary assigned to Crocodyliformes from the Adamantina Formation (Bauru Group, Upper Cretaceous), São Paulo, Brazil.

Cardia DFF, Bertini RJ, Camossi LG, Letizio LA.

An Acad Bras Cienc. 2019;91Suppl. 2(Suppl. 2):e20170848. doi: 10.1590/0001-3765201920170848. Epub 2019 May 6.

7.

Postoperative complications increase the risk of long-term chronic kidney disease after nephron-sparing surgery in patients with renal cancer and normal preoperative renal function.

Ventimiglia E, Larcher A, Trevisani F, Muttin F, Cianflone F, Montorsi F, Salonia A, Bertini R, Capitanio U.

BJU Int. 2019 Sep;124(3):457-461. doi: 10.1111/bju.14712. Epub 2019 Mar 20.

PMID:
30768877
8.

The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy.

Capogrosso P, Larcher A, Nini A, Muttin F, Cianflone F, Ripa F, Briganti A, Necchi A, Montorsi F, Salonia A, Bertini R, Capitanio U.

Urol Oncol. 2019 Apr;37(4):293.e25-293.e30. doi: 10.1016/j.urolonc.2019.01.009. Epub 2019 Jan 28.

PMID:
30704958
9.

Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project).

Mari A, Campi R, Schiavina R, Amparore D, Antonelli A, Artibani W, Barale M, Bertini R, Borghesi M, Bove P, Brunocilla E, Capitanio U, Da Pozzo L, Daja J, Gontero P, Larcher A, Li Marzi V, Longo N, Mirone V, Montanari E, Pisano F, Porpiglia F, Simeone C, Siracusano S, Tellini R, Trombetta C, Volpe A, Ficarra V, Carini M, Minervini A; Collaborators.

BJU Int. 2019 Jul;124(1):93-102. doi: 10.1111/bju.14680. Epub 2019 Feb 12.

PMID:
30653796
10.

The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma.

Nini A, Larcher A, Cazzaniga W, Dell'Oglio P, Cianflone F, Muttin F, Ripa F, Salonia A, Briganti A, Montorsi F, Bertini R, Capitanio U.

World J Urol. 2019 Aug;37(8):1623-1629. doi: 10.1007/s00345-018-2573-3. Epub 2018 Nov 24.

PMID:
30474699
11.

Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.

Antonelli A, Minervini A, Sandri M, Bertini R, Bertolo R, Carini M, Furlan M, Larcher A, Mantica G, Mari A, Montorsi F, Palumbo C, Porpiglia F, Romagnani P, Simeone C, Terrone C, Capitanio U.

Eur Urol. 2018 Nov;74(5):661-667. doi: 10.1016/j.eururo.2018.07.029. Epub 2018 Aug 10.

PMID:
30104082
12.

Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Muttin F, Pecoraro A, Larcher A, Dell'Oglio P, Nini A, Cianflone F, Trevisani F, Dehò F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

World J Urol. 2019 Apr;37(4):701-708. doi: 10.1007/s00345-018-2412-6. Epub 2018 Jul 25.

PMID:
30046844
13.

Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival.

Fichera D, Luciano R, Nini A, Freschi M, Doglioni C, Bertini R, Montorsi F, Capitanio U.

Arch Esp Urol. 2018 Jul;71(6):555-558. Review.

PMID:
29991665
14.

Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years.

DI Trapani E, Dell'oglio P, Larcher A, Nini A, Muttin F, Cianflone F, Dehò F, Matloob R, DI Trapani D, Freschi M, Salonia A, Briganti A, Montorsi F, Bertini R, Capitanio U.

Anticancer Res. 2018 Jul;38(7):4123-4130. doi: 10.21873/anticanres.12703.

PMID:
29970539
15.

The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.

Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, Regis F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

Front Surg. 2018 Mar 28;5:26. doi: 10.3389/fsurg.2018.00026. eCollection 2018.

16.

Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma.

Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell'Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, Capitanio U.

J Urol. 2018 Jul;200(1):61-67. doi: 10.1016/j.juro.2018.01.072. Epub 2018 Jan 31.

17.

Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.

Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC.

J Urol. 2018 May;199(5):1143-1148. doi: 10.1016/j.juro.2017.11.114. Epub 2017 Dec 7.

PMID:
29225056
18.

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium.

Nini A, Capitanio U, Larcher A, Dell'Oglio P, Dehò F, Suardi N, Muttin F, Carenzi C, Freschi M, Lucianò R, La Croce G, Briganti A, Colombo R, Salonia A, Castiglioni A, Rigatti P, Montorsi F, Bertini R.

Eur Urol. 2018 May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13.

PMID:
28917595
19.

When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy.

Larcher A, Muttin F, Fossati N, Dell'Oglio P, Di Trapani E, Stabile A, Ripa F, Trevisani F, Carenzi C, Picchio M, Briganti A, Salonia A, Mottrie A, Bertini R, Montorsi F, Capitanio U.

Urology. 2017 Dec;110:114-120. doi: 10.1016/j.urology.2017.08.043. Epub 2017 Sep 7.

PMID:
28890151
20.

Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.

Dell'Oglio P, Larcher A, Muttin F, Di Trapani E, Trevisani F, Ripa F, Carenzi C, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

Urol Oncol. 2017 Nov;35(11):662.e9-662.e15. doi: 10.1016/j.urolonc.2017.07.010. Epub 2017 Aug 8.

PMID:
28801027
21.

The Association of Uromodulin Genotype with Renal Cancer Aggressiveness.

Trevisani F, Larcher A, Cinque A, Capitanio U, Ripa F, Vago R, Bettiga A, Benigni F, Carenzi C, Muttin F, Bertini R, Briganti A, Salonia A, Rampoldi L, Montorsi F.

Eur Urol Focus. 2019 Mar;5(2):262-265. doi: 10.1016/j.euf.2017.04.009. Epub 2017 May 12.

PMID:
28753889
22.

Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.

Palencia A, Bougdour A, Brenier-Pinchart MP, Touquet B, Bertini RL, Sensi C, Gay G, Vollaire J, Josserand V, Easom E, Freund YR, Pelloux H, Rosenthal PJ, Cusack S, Hakimi MA.

EMBO Mol Med. 2017 Mar;9(3):385-394. doi: 10.15252/emmm.201607370.

23.

When to perform preoperative chest computed tomography for renal cancer staging.

Larcher A, Dell'Oglio P, Fossati N, Nini A, Muttin F, Suardi N, De Cobelli F, Salonia A, Briganti A, Zhang X, Montorsi F, Bertini R, Capitanio U.

BJU Int. 2017 Oct;120(4):490-496. doi: 10.1111/bju.13670. Epub 2016 Nov 2.

24.

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

Trevisani F, Ghidini M, Larcher A, Lampis A, Lote H, Manunta P, Alibrandi MT, Zagato L, Citterio L, Dell'Antonio G, Carenzi C, Capasso G, Rugge M, Rigotti P, Bertini R, Cascione L, Briganti A, Salonia A, Benigni F, Braconi C, Fassan M, Hahne JC, Montorsi F, Valeri N.

Br J Cancer. 2016 Nov 22;115(11):1343-1350. doi: 10.1038/bjc.2016.329. Epub 2016 Nov 1.

25.

Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses.

Gay G, Braun L, Brenier-Pinchart MP, Vollaire J, Josserand V, Bertini RL, Varesano A, Touquet B, De Bock PJ, Coute Y, Tardieux I, Bougdour A, Hakimi MA.

J Exp Med. 2016 Aug 22;213(9):1779-98. doi: 10.1084/jem.20160340. Epub 2016 Aug 8.

26.

Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.

Larcher A, Capitanio U, Terrone C, Volpe A, De Angelis P, Dehó F, Fossati N, Dell'Oglio P, Antonelli A, Furlan M, Simeone C, Serni S, Carini M, Minervini A, Fiori C, Porpiglia F, Briganti A, Montorsi F, Bertini R.

J Urol. 2016 Oct;196(4):1008-13. doi: 10.1016/j.juro.2016.04.093. Epub 2016 May 25.

28.

End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline.

Capitanio U, Larcher A, Terrone C, Antonelli A, Volpe A, Fiori C, Furlan M, Dehò F, Minervini A, Serni S, Porpiglia F, Trevisani F, Salonia A, Carini M, Simeone C, Montorsi F, Bertini R.

Eur Urol. 2016 Oct;70(4):558-561. doi: 10.1016/j.eururo.2016.03.023. Epub 2016 Mar 25.

PMID:
27021797
29.

Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines.

Capogrosso P, Capitanio U, La Croce G, Nini A, Salonia A, Montorsi F, Bertini R.

Eur Urol Focus. 2016 Feb;1(3):272-281. doi: 10.1016/j.euf.2015.04.001. Epub 2015 Jun 1. Review.

PMID:
28723399
30.

Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.

Capitanio U, Deho' F, Dell'Oglio P, Larcher A, Capogrosso P, Nini A, Carenzi C, Freschi M, Briganti A, Salonia A, Montorsi F, Bertini R.

World J Urol. 2016 Aug;34(8):1139-45. doi: 10.1007/s00345-015-1747-5. Epub 2015 Dec 15.

PMID:
26670425
31.

L'Ischémie n'est pas un facteur d'insuffisance rénale chronique après néphrectomie partielle sur rein unique.

Pignot G, Bahi R, Bensalah K, Oger E, Laguna P, Barwari K, Rigaud J, Rouprêt M, Bernhard J, Long J, Zisman A, Berger J, Paparel P, Lechevallier E, Bertini R, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez A, Patard J.

Prog Urol. 2014 Nov;24(13):822. doi: 10.1016/j.purol.2014.08.087. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461614
32.

Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii.

Brenier-Pinchart MP, Capderou E, Bertini RL, Bailly S, Fricker-Hidalgo H, Varlet-Marie E, Murat JB, Sterkers Y, Touafek F, Bastien P, Pelloux H.

Diagn Microbiol Infect Dis. 2015 Aug;82(4):289-91. doi: 10.1016/j.diagmicrobio.2015.04.004. Epub 2015 Apr 24.

PMID:
25957458
33.

A new species of Equinoxiodus (Dipnoi: ?Neoceratodontidae) from the Late Cretaceous of Brazil.

De Sousa EP, Medeiros MA, Toledo CE, Bertini RJ, Pereira AA, Lindoso RM.

Zootaxa. 2015 Jan 13;3905(3):397-406. doi: 10.11646/zootaxa.3905.3.5.

PMID:
25661218
34.

Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.

Colombo R, Pellucchi F, Moschini M, Gallina A, Bertini R, Salonia A, Rigatti P, Montorsi F.

World J Urol. 2015 Oct;33(10):1389-95. doi: 10.1007/s00345-015-1482-y. Epub 2015 Jan 11.

PMID:
25577131
35.

[Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency].

Bahi R, Pignot G, Hammoudi Y, Bensalah K, Oger E, Laguna P, Barwari K, Bessède T, Rigaud J, Roupret M, Bernhard JC, Long JA, Zisman A, Berger J, Paparel P, Lechevallier E, Bertini R, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez AR, Patard JJ.

Prog Urol. 2015 Jan;25(1):27-33. doi: 10.1016/j.purol.2014.09.039. Epub 2014 Oct 23. French.

PMID:
25450751
36.

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief.

Moriconi A, Cunha TM, Souza GR, Lopes AH, Cunha FQ, Carneiro VL, Pinto LG, Brandolini L, Aramini A, Bizzarri C, Bianchini G, Beccari AR, Fanton M, Bruno A, Costantino G, Bertini R, Galliera E, Locati M, Ferreira SH, Teixeira MM, Allegretti M.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16937-42. doi: 10.1073/pnas.1417365111. Epub 2014 Nov 10.

37.

Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.

Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M, Matloob R, Regis F, Fiori C, Porpiglia F, Di Trapani E, Zacchero M, Serni S, Salonia A, Carini M, Simeone C, Montorsi F, Bertini R.

Eur Urol. 2015 Apr;67(4):683-9. doi: 10.1016/j.eururo.2014.09.027. Epub 2014 Oct 3.

PMID:
25282367
38.

Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.

Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Feb;193(2):436-42. doi: 10.1016/j.juro.2014.07.087. Epub 2014 Jul 22.

PMID:
25063493
39.

Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.

Pignot G, Bigot P, Bernhard JC, Bouliere F, Bessede T, Bensalah K, Salomon L, Mottet N, Bellec L, Soulié M, Ferrière JM, Pfister C, Drai J, Colombel M, Villers A, Rigaud J, Bouchot O, Montorsi F, Bertini R, Belldegrun AS, Pantuck AJ, Patard JJ.

Urol Oncol. 2014 Oct;32(7):1024-30. doi: 10.1016/j.urolonc.2014.03.012. Epub 2014 Jul 2.

PMID:
24996775
40.

Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).

Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R.

BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22.

41.

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Faba OR, Russo P, Shariat SF, Spahn M, Terrone C, Tilki D, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA.

Curr Urol Rep. 2014 May;15(5):404. doi: 10.1007/s11934-014-0404-7. Review.

PMID:
24682884
42.

Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A.

Eur Urol. 2015 Feb;67(2):299-309. doi: 10.1016/j.eururo.2014.02.011. Epub 2014 Feb 18.

PMID:
24571959
43.
44.

The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.

Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R.

Urol Oncol. 2014 Jan;32(1):43.e9-16. doi: 10.1016/j.urolonc.2013.05.006. Epub 2013 Aug 2.

PMID:
23911684
45.

Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).

Brookman-May SD, May M, Shariat SF, Novara G, Zigeuner R, Cindolo L, De Cobelli O, De Nunzio C, Pahernik S, Wirth MP, Longo N, Simonato A, Serni S, Siracusano S, Volpe A, Morgia G, Bertini R, Dalpiaz O, Stief C, Ficarra V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group.

BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25.

46.

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.

PMID:
23871402
47.

Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis.

Vezzoli G, Terranegra A, Aloia A, Arcidiacono T, Milanesi L, Mosca E, Mingione A, Spotti D, Cusi D, Hou J, Hendy GN, Soldati L; GENIAL network (Genetics and Environment in Nephrolithiasis Italian Alliance), Paloschi V, Dogliotti E, Brasacchio C, Dell'Antonio G, Montorsi F, Bertini R, Bellinzoni P, Guazzoni G, Borghi L, Guerra A, Allegri F, Ticinesi A, Meschi T, Nouvenne A, Lupo A, Fabris A, Gambaro G, Strazzullo P, Rendina D, De Filippo G, Brandi ML, Croppi E, Cianferotti L, Trinchieri A, Caudarella R, Cupisti A, Anglani F, Del Prete D.

J Clin Endocrinol Metab. 2013 Sep;98(9):3839-47. doi: 10.1210/jc.2013-1834. Epub 2013 Jul 17.

48.

When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up.

Capitanio U, Abdollah F, Matloob R, Suardi N, Castiglione F, Di Trapani E, Capogrosso P, Gallina A, Dell'Oglio P, Briganti A, Salonia A, Montorsi F, Bertini R.

BJU Int. 2013 Jul;112(2):E59-66. doi: 10.1111/bju.12125.

49.

Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study.

Verhoest G, Patard JJ, Oger E, Rioux-Leclercq N, Peyronnet B, Bessède T, Laguna P, Barwari K, Rigaud J, Roupret M, Coffin G, Bernhard JC, Long JA, Zisman A, Berger J, Paparel P, Maurin C, Lechevallier E, Bertini R, Ouzaid I, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez AR, Bensalah K.

Urol Oncol. 2014 Jan;32(1):28.e21-6. doi: 10.1016/j.urolonc.2012.10.003. Epub 2013 Feb 19.

PMID:
23428536
50.

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.

Capitanio U, Abdollah F, Matloob R, Salonia A, Suardi N, Briganti A, Carenzi C, Rigatti P, Montorsi F, Bertini R.

Int J Urol. 2013 Jun;20(6):572-9. doi: 10.1111/iju.12004. Epub 2012 Nov 19.

Supplemental Content

Loading ...
Support Center